M&A
-
Ginger CEO: ‘It felt like the right time’ for Headspace merger
At CB Insights’ Future of Health Conference, Ginger CEO Russell Glass talked about how the company merged with Headspace to form a $3 billion mental health company and how to scale up a mental health business.
-
Devices & Diagnostics, Health Tech
Philips builds on cardiac monitoring with Cardiologs acquisition
Paris-based Cardiologs has a software platform to screen for arrhythmias from ECG data. It would add to Philips’ portfolio of cardiac software for hospitals and remote monitoring.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
UnitedHealth, Change meet requirements for DOJ investigation, agree not to merge before February
The companies have certified substantial compliance with a request for additional information from the Department of Justice, which opened an investigation of the merger in March. They struck an agreement with the agency not to merge until February of 2022, unless it drops its investigation before then.
-
Devices & Diagnostics, MedCity Influencers, SYN
Device companies are cash-rich and looking to acquire. Here’s why that is good.
Agile, nimble entrepreneurs with a vision can often chart a course through the big guys to serve emerging needs or those that rarely get attention
-
Why Virgin Pulse bought Welltok
The merger of the two patient engagement companies will create an organization with more than 2,000 employees. The deal would expand Virgin Pulse’s channels for communicating with patients and help it expand into some new markets.
-
Health IT, Health Tech, Pharmacy
Report: Walgreens considers acquiring health IT company Evolent
Walgreens is considering buying Evolent Health, which makes software to help providers manage their value-based care programs, according to a recent report by Bloomberg. Evolent’s stock rose more than 18% on the news of the potential deal.
-
Devices & Diagnostics, Health Tech
Report: Medtech M&A jumps as companies bounce back from the pandemic
Medical technology companies saw 288 deals between June 2020 and June 2021, the highest amount ever since Ernst & Young began tracking it in 2007. VC funding in medtech also reached a high point of $9.1 billion.
-
Health IT, Artificial Intelligence
Flywheel raises $22M, buys competitor
After closing a series C round led by 8VC, Flywheel used a portion of the funds to acquire St. Louis-based Radiologics. Both have platforms to help researchers process medical imaging data.
-
Why Medtronic decided to move now on its $1.1B Intersect ENT deal
Investors had long expected Intersect ENT to be an acquisition target before Medtronic announced its plans to buy the company last week. Better reimbursement for Intersect ENT’s products and elective procedures returning over the summer months might have helped the deal cross the finish line.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Health Tech, Patient Engagement
Relatient plans to beef up patient engagement software with Radix acquisition
Relatient, a company that makes patient engagement software, recently raised more than $100 million in growth equity capital. It plans to put a portion of the funds to acquire startup Radix Health.
-
Report: Fewer health system M&A deals in Q1 2021 offset by larger transactions
Though the number of merger and acquisition deals in the first quarter of 2021 fell below historical averages, the size of the deals was far bigger than the same period last year, a new report from Kaufman Hall shows. The total transacted revenue was $8.8 billion, the second-highest Q1 figure in the last five years.
-
Hillrom faces lawsuit after dropping planned $375M Bardy Diagnostics deal
Hillrom axed plans to acquire cardiac monitoring company Bardy Diagnostics over reimbursement changes by a Medicare contractor. Bardy filed suit against Hillrom on Sunday.
-
Employee Benefits, Health Services
Accolade to acquire second-opinion platform for $460M
Benefits navigation startup Accolade acquired second opinion startup 2nd.MD for $460 million. With little overlap between the two companies, the deal is expected to increase Accolade’s total addressable market by $22 billion.
-
Startups, Health Services, Health Tech
Health-tech funding breaks another record in 2020
Healthcare technology companies raised a record of $15.3 billion in 2020, according to a report from Silicon Valley Bank. For the first time, digital health companies surpassed biopharma for the number of deals.
-
BMS acquires MyoKardia, maker of drugs for cardiovascular disease, for $13.1B
The companies expect the deal to close in the fourth quarter. MyoKardia’s lead drug candidate is mavacamten, which it is developing for hypertrophic cardiomyopathy and plans to submit to the FDA in the first quarter of next year.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
